KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,000 | -20.4% | 5,123 | -0.2% | 0.00% | – |
| Q2 2023 | $206,000 | +102.0% | 5,135 | +114.7% | 0.00% | – |
| Q1 2023 | $102,000 | -28.7% | 2,392 | -19.3% | 0.00% | – |
| Q4 2022 | $143,000 | +694.4% | 2,965 | +519.0% | 0.00% | – |
| Q3 2022 | $18,000 | +80.0% | 479 | +34.6% | 0.00% | – |
| Q2 2022 | $10,000 | -85.1% | 356 | -71.2% | 0.00% | – |
| Q1 2022 | $67,000 | -68.8% | 1,235 | -66.4% | 0.00% | – |
| Q4 2021 | $215,000 | +277.2% | 3,676 | +156.5% | 0.00% | – |
| Q3 2021 | $57,000 | +16.3% | 1,433 | +22.6% | 0.00% | – |
| Q2 2021 | $49,000 | -38.0% | 1,169 | -8.9% | 0.00% | – |
| Q1 2021 | $79,000 | +154.8% | 1,283 | +187.7% | 0.00% | – |
| Q4 2020 | $31,000 | +675.0% | 446 | +341.6% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 101 | +1.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 276,000 | $7,626,000 | 3.44% |
| First Light Asset Management, LLC | 598,333 | $16,532,000 | 1.92% |
| Fairmount Funds Management LLC | 272,498 | $7,529,000 | 1.72% |
| Deep Track Capital, LP | 739,528 | $20,433,000 | 1.34% |
| Nantahala Capital Management | 911,901 | $25,196,000 | 1.26% |
| Octagon Capital Advisors LP | 152,249 | $4,207,000 | 1.12% |
| CHI Advisors LLC | 103,429 | $2,858,000 | 1.09% |
| Altium Capital Management LP | 88,000 | $2,431,000 | 0.97% |
| Orbimed Advisors | 1,679,417 | $46,402,000 | 0.84% |
| Parkman Healthcare Partners LLC | 47,788 | $1,320,000 | 0.49% |